Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-clas…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-clas…
BayPAT, a service provider offering services in the area of technology transfer, IP management and commercialisation, to…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-clas…
Already at the end of the 19th century it became known that injections can cause severe fever in patients. Substances ca…
. - Results confirm IMU-935 as a potent inverse agonist of RORgt with an IC50 of 24 nM, leading to potent inhibition of…
Major Key Players: Leading players profiled in the cancer immunotherapy market include Spectrum Pharmaceuticals, Inc.…
Transaction Expected to Create NASDAQ-listed Biopharmaceutical Company Focused on Advancing Immunic‘s Compelling Pipelin…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), société de biotechnologie développant principalement des traitements…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), société de biotechnologie développant principalement des traitements…
